AbbVie

YTD

ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.

CEO

Robert A. Michael

CEORobert A. Michael

Employees

55,000

Employees55,000

Headquarters

North Chicago, Illinois

HeadquartersNorth Chicago, Illinois

Founded

2011

Founded2011

Employees

55,000

Employees55,000

ABBV Key Statistics

Market cap

321.01B

Market cap321.01B

Price-Earnings ratio

78.82

Price-Earnings ratio78.82

Dividend yield

3.45%

Dividend yield3.45%

Average volume

8.32M

Average volume8.32M

High today

$184.81

High today$184.81

Low today

$181.00

Low today$181.00

Open price

$183.77

Open price$183.77

Volume

5.14M

Volume5.14M

52 Week high

$218.66

52 Week high$218.66

52 Week low

$153.58

52 Week low$153.58

ABBV News

TipRanks 5d

Perion, Sea, KKR, Chimera, AbbVie: Trending by Analysts

Analysts are intrested in these 5 stocks: ( (PERI) ), ( (SE) ), ( (KKR) ), ( (CIM) ) and ( (ABBV) ). Here is a breakdown of their recent ratings and the rationa...

Simply Wall St 5d

AbbVie's Soft Earnings Are Actually Better Than They Appear

The market was pleased with the recent earnings report from AbbVie Inc. ( ), despite the profit numbers being soft. We think that investors might be looking at...

Analyst ratings

60%

of 30 ratings

Buy

60%

Hold

36.7%

Sell

3.3%

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.